|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
A Pilot Study of Individualized
Maximum Repeatable Dose (Imrd), A New Dose Finding System, of
Weekly Gemcitabine for Patients With Metastatic Pancreas Cancer Pancreas. 2005 Apr;30(3):206-10. PMID: 15782095
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |